Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Stroke

• Publication date

  2004-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.0000147965.52712.faPMID 15514180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

  2004cited by this paper
• Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study (Cerebrovasc Dis 2003;16:389-395)

  2004cited by this paper
• Stroke : pathophysiology, diagnosis, and management

  2004cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness

  2002cited by this paper
• Low Concentration of Serum Total Cholesterol Is Associated With Multifocal Signal Loss Lesions on Gradient-Echo Magnetic Resonance Imaging: Analysis of Risk Factors for Multifocal Signal Loss Lesions

  2002cited by this paper
• Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

  2002cited by this paper
• Effects of Atorvastatin on Stroke in Patients With Unstable Angina or Non-Q-Wave Myocardial Infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Substudy

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

  2001cited by this paper
• Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques: Implications for Plaque Stabilization

  2001cited by this paper
• Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction

  2001cited by this paper
• Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.

  2001cited by this paper
• Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial.

  2001cited by this paper
• Reduction of Stroke Events With Pravastatin: The Prospective Pravastatin Pooling (PPP) Project

  2001cited by this paper
• Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.

  2001cited by this paper
• Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis: The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)

  2000cited by this paper
• PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA

  2000cited by this paper
• Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).

  2000cited by this paper
• Pravastatin use and risk of coronary events and cerebral infarction in japanese men with moderate hypercholesterolemia: the Kyushu Lipid Intervention Study.

  2000cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Pravastatin therapy and the risk of stroke.

  2000cited by this paper
• Pravastatin therapy and the risk of stroke.

  2000cited by this paper
• Effect of simvastatin on coronary atheroma

  2000cited by this paper
• Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia.

  1999cited by this paper
• Cross-Sectional and 4-Year Longitudinal Associations Between Brachial Pulse Pressure and Common Carotid Intima-Media Thickness in a General Population

  1999cited by this paper
• The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk.

  1999cited by this paper
• Cross-sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intima-media thickness in a general population. The EVA study.

  1999cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS).

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.

  1998cited by this paper
• Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

  1998cited by this paper
• Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis Results of the LIPID Atherosclerosis Substudy

  1998cited by this paper
• The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

  1997cited by this paper
• Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors.

  1997cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis.

  1997cited by this paper
• Reductase inhibitor monotherapy and stroke prevention.

  1997cited by this paper
• Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study.

  1996cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

  1995cited by this paper
• Implications of small reductions in diastolic blood pressure for primary prevention.

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy.

  1995cited by this paper
• Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

  1995cited by this paper
• Effect of Cholesterol-Lowering Medications on Progression of Mild Atherosclerotic Lesions of the Carotid Arteries and on the Risk of Stroke

  1995cited by this paper
• Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

  1995cited by this paper
• Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

  1995cited by this paper
• Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

  1995cited by this paper
• Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.

  1995cited by this paper
• Effect of simvastatin on coronary atheroma

  1994cited by this paper
• Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin.

  1994cited by this paper
• Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart study

  1994cited by this paper
• Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.

  1994cited by this paper
• Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

  1994cited by this paper
• Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

  1994cited by this paper
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.

  1993cited by this paper
• Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)

  1993cited by this paper
• Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.

  1992cited by this paper
• The Honolulu Heart Program

  1991cited by this paper
• Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program.

  1989cited by this paper
• Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

  1989cited by this paper
• The epidemiology of stroke.

  1979cited by this paper

• Management of Dyslipidemia in Patients with Diabetes Mellitus and Cardiovascular Disease

  2026cites this paper
• Contemporary Medical Management of Carotid Artery Stenosis

  2026cites this paper
• Changes in symptomatic intracranial atherosclerotic plaques and perforating arteries under medical treatment using high-resolution magnetic resonance imaging

  2025cites this paper
• Miastenia gravis desencadenada por el uso de estatinas: presentación de once casos

  2025cites this paper
• Cerebrovascular accidents – Unexpected complication of systemic sclerosis: A scarce case report

  2025cites this paper
• The journey to improving stroke risk stratification for patients with carotid artery stenosis: from medical management to revascularization.

  2025cites this paper
• Association between statin treatment and outcomes among critically ill acute ischemic stroke patients.

  2025cites this paper
• Influence of Persistently Elevated LDL Values on Carotid Intima Media Thickness in Elite Athletes

  2025cites this paper
• Metabolically Abnormal Obesity and Carotid Plaque Vulnerability: A Vessel Wall MRI Study Linking Obesity Phenotypes to Atherosclerotic Instability

  2025cites this paper
• Atorvastatin alleviates atherosclerosis by improving intestinal barrier function in mice and patients by modulating inflammation.

  2025cites this paper
• Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population

  2025cites this paper
• Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation

  2025cites this paper
• Safety of simultaneous bilateral internal carotid artery stenting

  2025cites this paper
• Potenziell inadäquate Medikation im letzten Lebensmonat

  2025cites this paper
• Low Density Lipoprotein Cholesterol but not Statins is the Direct Cause of Intracerebral Hemorrhage.

  2025cites this paper
• Effects of statins on restenosis after carotid artery stenting.

  2025cites this paper
• Management and outcomes of asymptomatic carotid stenosis in octogenarians and nonagenarians.

  2025cites this paper
• Higher High‐Density Lipoprotein Cholesterol Levels Are Associated With an Unfavorable Outcome After Thrombolysis for Stroke: The Lipid Paradox

  2025cites this paper
• Dual-Energy Computed Tomography Analysis of Carotid Calcified Plaques in Stroke Patients

  2025cites this paper
• Statins in Acute Ischemic Stroke: Mechanisms, Resistance, and Precision Strategies for Neurovascular and Cognitive Protection

  2025cites this paper
• Achieving More Optimal Lipid Control with Non-Statin Lipid Lowering Therapy

  2025cites this paper
• Developing Therapeutically Enhanced Extracellular Vesicles for Atherosclerosis Therapy

  2025cites this paper
• An Outpatient Pharmacist Strategy Improves Guideline Adherent Medication Prescribing in Patients with Vascular Disease.

  2025cites this paper
• Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

  2025cites this paper
• Immunoglobulin G N-glycosylation predicts long-term risk of ischemic stroke: a nested case-control study

  2025cites this paper
• The Efficacy and Safety of Inclisiran for Low-Density Lipoprotein (LDL) in Patients With Atherosclerotic Cardiovascular Disease (ASCVD): A Systematic Review of Randomized Controlled Trials

  2024cites this paper
• Early statin use is associated with improved outcomes in patients with atrial fibrillation and recent ischaemic stroke.

  2024cites this paper
• The association between statin use and non-Hodgkin lymphoma; a systematic review and meta-analysis

  2024cites this paper
• Effects of statin use on serum creatinine phosphokinase levels in normal thyroid function

  2024cites this paper
• Global trends and research hotspots of PCSK9 and cardiovascular disease: a bibliometric and visual analysis

  2024cites this paper
• Brazilian Angiology and Vascular Surgery Society Guidelines for the treatment of extracranial cerebrovascular disease

  2024cites this paper
• Trends in Demographic and Geographic Disparities in Stroke Mortality Among Older Adults in the United States.

  2024cites this paper
• Intracranial and Extracranial Vertebrobasilar Artery Stenosis Patient Profile in Dr. Moewardi General Hospital

  2024cites this paper
• Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity

  2024cites this paper
• Statin Initiation and early stroke recurrence in the POINT Trial Population

  2024influential citation
• Advances in the molecular mechanisms of statins in regulating endothelial nitric oxide bioavailability: Interlocking biology between eNOS activity and L-arginine metabolism.

  2024cites this paper
• Association between small dense low-density lipoprotein and carotid intima-media thickness

  2024cites this paper
• Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures

  2024cites this paper
• Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities

  2024cites this paper
• Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database

  2024cites this paper
• Phase 1 Evaluation of the Bioequivalence and Drug‐Drug Interaction Potential of a Novel Fixed‐Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine

  2024cites this paper
• An evolution in carotid care: Contemporary TCAR data and optimization techniques

  2024cites this paper
• Effect of PCSK9 inhibition in combination with statin therapy on intracranial atherosclerotic stenosis: A high-resolution MRI study

  2023cites this paper
• Frequency of Deranged Lipid Profile in Patients with Stroke

  2023cites this paper
• The Attributable Risk of Nonstenotic Cervical Carotid Plaque in Cryptogenic Embolic Stroke

  2023cites this paper
• What are the benefits and drawbacks of statins in carotid artery disease? A perspective review

  2023influential citation
• Effect of Combination Therapy with Ezetimibe and Statins versus Statin Monotherapy on Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2023influential citation
• Development of a Three-Dimensional Carotid Ultrasound Image Segmentation Workflow for Improved Efficiency, Reproducibility and Accuracy in Measuring Vessel Wall and Plaque Volume and Thickness

  2023cites this paper
• Implementation of clinical medication review in a geriatric ward to reduce potentially inappropriate prescriptions among older adults

  2023cites this paper
• New Targets in Atherosclerosis: Vascular Smooth Muscle Cell Plasticity and Macrophage Polarity.

  2023cites this paper
• Efficacy and safety of inclisiran in stroke or cerebrovascular disease prevention: a systematic review and meta-analysis of randomized controlled trials

  2023cites this paper
• Moxonidine Increases Uptake of Oxidised Low-Density Lipoprotein in Cultured Vascular Smooth Muscle Cells and Inhibits Atherosclerosis in Apolipoprotein E-Deficient Mice

  2023cites this paper
• The 2023 Taiwan Stroke Society Guidelines for the management of patients with intracranial atherosclerotic disease

  2023cites this paper
• Contemporary Treatment of the Asymptomatic Carotid Patient.

  2023cites this paper
• Associations of lipids and lipid-lowering drugs with risk of stroke: a Mendelian randomization study

  2023cites this paper
• Statins in Epilepsy: From Mechanisms to Evidence

  2022cites this paper
• Potentially inappropriate prescribing in older adults with cancer receiving specialist palliative care: a retrospective observational study

  2022cites this paper
• Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)

  2022cites this paper
• Intensive lipid lowering agents and coronary atherosclerosis: Insights from intravascular imaging

  2022cites this paper
• Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease.

  2022cites this paper
• Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes?

  2022cites this paper
• The preventive effect of the combination of atorvastatin and nortriptyline in migraine-type headache: a randomized, triple-blind, placebo-controlled trial

  2022cites this paper
• Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology.

  2022cites this paper
• Echolucent carotid plaques becomes more echogenic over time - a 3D ultrasound study.

  2022cites this paper
• Epidemiological Study of Cerebrovascular Stroke in Minia Governorate (The Aural Community)

  2022cites this paper
• Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults

  2022cites this paper
• Decreased Risk of Stroke in People Using Red Yeast Rice Prescriptions (LipoCol Forte®): a Total Population-Based Retrospective Cohort Study

  2022cites this paper
• Epidemiological aspects of carotid disease

  2021cites this paper
• INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"

  2021cites this paper
• LDL cholesterol and atherosclerosis: The evidence.

  2021cites this paper
• Aspects of practical application of ‘STOPP/START’ criteria in elderly patients with atrial fibrillation and chronic kidney disease in therapeutic department of multi‑speciality hospital

  2021cites this paper
• Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids

  2021cites this paper
• Egyptian practical guidance in lipid management 2020

  2021cites this paper
• Embolischer Schlaganfall mit ungeklärter Emboliequelle (ESUS) – Klassifikation einer neuen Schlaganfallentität

  2021cites this paper
• A Model for Risk Prediction of Cerebrovascular Disease Prevalence—Based on Community Residents Aged 40 and above in a City in China

  2021cites this paper
• Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids

  2021cites this paper
• The Role of Carotid Stenosis in a Prediction of Prognosis of Coronary Artery Disease

  2021cites this paper
• Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An International, multispecialty, expert review and position statement.

  2021cites this paper
• Rates of intervention for claudication versus chronic limb-threatening ischemia in Canada and United States.

  2021cites this paper
• Statin therapy associated with decreased neuronal injury measured by serum S100β levels in patients with acute ischemic stroke

  2021cites this paper
• Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India.

  2021cites this paper
• Symptom status of patients undergoing carotid endarterectomy in Canada and United States.

  2021cites this paper
• Autophagy is induced and modulated by cholesterol depletion through transcription of autophagy-related genes and attenuation of flux

  2021cites this paper
• Low-Dose Piperlongumine Rescues Impaired Function of Endothelial Progenitor Cells and Reduces Cerebral Ischemic Injury in High-Fat Diet-Fed Mice

  2021cites this paper
• Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement.

  2021cites this paper
• Efficacy and Safety of PCSK9 Inhibitors in Stroke Prevention.

  2021cites this paper
• The quality of medication optimization among patients with transient ischemic attack or minor stroke

  2020cites this paper
• Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review

  2020cites this paper
• Apolipoproteins A1 and B and their ratio in acute ischemic stroke patients with intracranial and extracranial arterial stenosis: an Egyptian study

  2020cites this paper
• A Functional Polymorphism in HIF-3α Is Related to an Increased Risk of Ischemic Stroke

  2020cites this paper
• Association of LDLc to HDLc ratio with carotid plaques in a community-based population with a high stroke risk: a cross-sectional study in China.

  2020cites this paper
• Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease—Pathogenesis and Pharmacological Treatment Options

  2020cites this paper
• Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology.

  2020cites this paper
• Usefulness of Carotid Ultrasonography for Risk Stratification of Cerebral and Cardiovascular Disease

  2020cites this paper
• Rivaroxaban in patients with ischaemic chronic cardiomyopathy and obstructive peripheral arterial disease: rationale for treatment and results

  2020cites this paper
• Arterial Structure and Function during and after Long-Duration Spaceflight.

  2020cites this paper
• Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin

  2020cites this paper
• Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression

  2020cites this paper
• Transient Ischemic Attack: Timely Diagnosis and Early Intervention

  2020cites this paper
• Meta-Analysis of Dyslipidemia Management for the Prevention of Ischemic Stroke Recurrence in China

  2020cites this paper